Similarly, the up-regulation of STAT1 represents a serious risk for human health since its activation is able to down-regulate programmed cell death genes in several cancer cell lines (i.e., breast cancer and adenocarcinoma cells) [69,70,71]. The gene discussed is STAT1; the disease is breast cancer.